Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiarui Chi

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Frontiers in Artificial Intelligence|February 6, 2026
Interpretable multimodal reasoning for robo-advisory: the FinErva frameworkJiarui Chi
Pharmaceutical Statistics|February 6, 2024
A case study: Assessing the efficacy of the revised dosage regimen via prediction model for recurrent event rate using biomarker dataAhrim Youn, Jiarui Chi, Yue Cui, et al.
Blood|March 7, 2024
Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trialGili Kenet, Beatrice Nolan, Bulent Zulfikar, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Frontiers in Artificial Intelligence|February 6, 2026
Interpretable multimodal reasoning for robo-advisory: the FinErva frameworkJiarui Chi
Pharmaceutical Statistics|February 6, 2024
A case study: Assessing the efficacy of the revised dosage regimen via prediction model for recurrent event rate using biomarker dataAhrim Youn, Jiarui Chi, Yue Cui, et al.
Blood|March 7, 2024
Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trialGili Kenet, Beatrice Nolan, Bulent Zulfikar, et al.
Pageof 1